Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes re... Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0241 | 8.1281618887 | 0.2965 | 0.3206 | 0.2965 | 1685 | 0.30580828 | CS |
| 4 | -0.0268 | -7.7144502015 | 0.3474 | 0.45878 | 0.2389 | 38811 | 0.29610832 | CS |
| 12 | 0.2826 | 743.684210526 | 0.038 | 0.45878 | 0.03075 | 27709 | 0.29963599 | CS |
| 26 | 0.2855 | 813.39031339 | 0.0351 | 0.45878 | 0.023 | 16768 | 0.21307418 | CS |
| 52 | 0.2716 | 554.285714286 | 0.049 | 0.45878 | 0.023 | 12642 | 0.1380413 | CS |
| 156 | 0.163 | 103.426395939 | 0.1576 | 0.45878 | 0.023 | 13602 | 0.09154474 | CS |
| 260 | 0.2268 | 241.791044776 | 0.0938 | 9.2795 | 0.023 | 41367 | 0.16098845 | CS |
McMagyar
2月前
McMagyar
3月前
smoki
3月前
smoki
3月前
McMagyar
7月前
McMagyar
9月前
McMagyar
1年前
McMagyar
1年前
tcm7
1年前
LuckyMarble
2年前
McMagyar
2年前
McMagyar
2年前
McMagyar
2年前
McMagyar
2年前
McMagyar
2年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。